SEC Form 4 · accession 0001179110-16-028546
Traws Pharma, Inc. · TRAW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jerome Groopman
Director
Period of report
Jun 29, 2016
Accepted (ET)
Aug 10, 2016 · 8:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001130598
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 29, 2016 | M | 10 | $5.20 | A | 10 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $5.20 | Jun 29, 2016 | M | 10 | D | Jun 18, 2016 | May 18, 2026 | Common Stock | 10 | 990 | D |
Remarks
Exhibit 24 - Power-of-Attorney attached.